Regulatory twists and turns are coming for biopharma in 2024

Aman Khera, shared insights with PharmaVoice on navigating some of the regulatory twists and turns to come in 2024 due to the impacts of the new FDA requirements and the federal Inflation Reduction Act. Learn Aman’s five key tips for regulatory success amid this shifting biopharma landscape. Read the article here.